Merck
CN
  • Urinary 2-ethyl-3-oxohexanoic acid as major metabolite of orally administered 2-ethylhexanoic acid in human.

Urinary 2-ethyl-3-oxohexanoic acid as major metabolite of orally administered 2-ethylhexanoic acid in human.

Molecular nutrition & food research (2007-02-20)
Dana Stingel, Peter Feldmeier, Elke Richling, Michael Kempf, Sandra Elss, Samira Labib, Peter Schreier
ABSTRACT

Human metabolism of 2-ethylhexanoic acid (2-EHA), which is a known metabolite of important phthalates, was investigated using 2-EHA-contaminated food. The results of our studies reveal that the major catabolic pathway of 2-EHA in human is beta-oxidation. The dominant final urinary metabolite was identified and quantified as 3-oxo-2-ethylhexanoic acid (3-oxo-2-EHA), but only after immediate methylation of the extract from urine and prior to GC-MS analysis. Former studies without the precaution of immediate methylation had found 4-heptanone as the major metabolite, which is obviously an artifact arising from the decarboxylation of 3-oxo-2-EHA.

MATERIALS
Product Number
Brand
Product Description

Supelco
2-Ethylhexanoic acid, analytical standard
Sigma-Aldrich
2-Ethylhexanoic acid, ≥99%
Sigma-Aldrich
2-Ethylhexanoic acid, ≥99%
Sigma-Aldrich
2-Ethylhexanoic acid, 99%